NCT02380092View on ClinicalTrials.gov

Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™

Active, not recruitingOBSERVATIONAL
Enrollment

163

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Degenerative Joint Disease
Interventions
DEVICE

LEGION™ Primary TKS with VERILAST™ Bearing Surface

All study subjects will be treated with LEGION™ Primary TKS with VERILAST™ Bearing Surface as per standard clinical practice.

Trial Locations (7)

1180

Evangelisches Krankenhaus Wien, Vienna

Orthopadische Krankenhaus Gersthof, Vienna

15706

Servicio de C.O.T. Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela

20149

OrthoCentrum, Hamburg

27607

AMEOS Klinikum Seepark Geestland, Langen

66125

CaritasKlinikum St. Joseph Saarbrücken-Dudweiler, Saarbrücken-Dudweiler

94315

KniePraxis Prof. Dr. Tibesku, Straubing

All Listed Sponsors
lead

Smith & Nephew, Inc.

INDUSTRY

NCT02380092 - Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™ | Biotech Hunter | Biotech Hunter